The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“We and other researchers have gathered compelling evidence, from yeast to mammals, supporting the idea that a loss of epigenetic information, resulting in changes in gene expression, leads to the loss of cellular identity [3–7].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · cited 1×
“b-catenin is the central effector in the canonical Wnt signaling pathway that controls stem cell maintenance, development and carcinogenesis [20].”
BackgroundActivation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905 · cited 1×
“. Constitutive activation of the β-catenin pathway has been found in 90% of colorectal cancers”
BackgroundModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“On the other hand, SIRT1 can be proapoptotic [12] and anti-proliferative [13,14], and consequently has been proposed to behave as a tumor suppressor in vivo.”
BackgroundCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationIncreased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 2×
“Interestingly, two recent studies have shown that increased Wnt signaling is associated with accelerated aging, suggesting that an attenuation of Wnt signaling might underlie CR and be beneficial not only for treating cancer but for more broadly attenuating diseases of aging [23,24].”
BackgroundMultiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Self-citationAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“of the second allele leads to constitutive nuclear localization of bcatenin and adenoma formation [18,19].”
BackgroundSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147
Cited by
Items 101–200 of 603
Côté, C. D., Rasmussen, B. A., Duca, F. A., Zadeh‐Tahmasebi, M., Baur, J. A., Daljeet, M., Breen, D. M., Filippi, B., & Lam, T. K. T. (2015) · Nature Medicine · doi:10.1038/nm.3821 · Cited by 164
Sirtuin 1 (SIRT1): The Misunderstood HDAC
Stünkel, W., & Campbell, R. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422103 · Cited by 168
Marshall, G. M., Liu, P. Y., Gherardi, S., Scarlett, C. J., Bedalov, A., Xu, N., Iraci, N., Valli, E., Ling, D., Thomas, W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002135 · Cited by 155
“On the other hand, by deacetylating catenin and survivin, SIRT1 can block cell proliferation and promote apoptosis [19,20].”
BackgroundExpression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
Lee, H., Kim, K. R., Noh, S. J., Park, H. S., Kwon, K. S., Park, B., Jung, S. H., Youn, H. J., Lee, B. K., Chung, M. J., et al. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.05.023 · Cited by 166
Circadian clocks and breast cancer
Blakeman, V., Williams, J. L., Meng, Q., & Streuli, C. H. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0743-z · Cited by 164
“For example, SIRT1 reduces proliferation by deacetylating β-catenin [25] and binding p53 [26], whereas TIMELESS advances the circadian clock in response to DNA damage [27, 28].”
SIRT1 Is Essential for Oncogenic Signaling by Estrogen/Estrogen Receptor α in Breast Cancer
Elangovan, S., Ramachandran, S., Venkatesan, N., Ananth, S., Gnana-Prakasam, J. P., Martin, P. M., Browning, D. D., Schoenlein, P. V., Prasad, P. D., Ganapathy, V., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1446 · Cited by 151
“SIRT1 suppresses intestinal tumorigenesis and colon cancer growth in a b-catenin–driven mouse model of colon cancer (14).”
BackgroundHwang, J.-W., Chung, S., Sundar, I. K., Yao, H., Arunachalam, G., McBurney, M. W., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.013 · Cited by 148
Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma
Lee, H.-Y., Nga, H. T., Tian, J., & Yi, H. (2021) · Cells · doi:10.3390/cells10081901 · Cited by 169
“PGC-1α is a key regulatory target of sirtuin-1 (SIRT1) [19], which can act as a tumor promoter or suppressor depending on the tumor cell type [20,21].”
BackgroundHistone deacetylase inhibitors in hematological malignancies and solid tumors
Chun, P. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0571-1 · Cited by 160
“However, in a colon cancer mouse model, increased SIRT1 expression suppressed cell proliferation and tumor formation (Firestein et al. 2008).”
BackgroundSIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
Mao, B., Hu, F., Cheng, J., Wang, P., Xu, M., Yuan, F., Meng, S., Wang, Y., Yuan, Z., & Bi, W. (2013) · Oncogene · doi:10.1038/onc.2013.88 · Cited by 157
Biochemical effects of SIRT1 activators
Baur, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.025 · Cited by 145
“However, SIRT1-dependent mechanisms may also play a role, since SIRT1 overexpression is sufficient to blunt intestinal tumorigenesis [52], and mice lacking SIRT1 exhibit a markedly reduced protective effect when given resveratrol as a preventive agent for skin cancer [45].”
BackgroundThe Tale of Protein Lysine Acetylation in the Cytoplasm
Sadoul, K., Wang, J., Diagouraga, B., & Khochbin, S. (2011) · BioMed Research International · doi:10.1155/2011/970382 · Cited by 140
“Most proteins, which shuttle between the nucleus and the cytoplasm, are acetylated by p300/CBP, including HNF-4, CIITA, PCNA, SRY, cAbl, CtBP2, p53, PAP, and β-catenin, RECQL4 [148–157].”
BackgroundJanus‐faced role of SIRT1 in tumorigenesis
Song, N., & Surh, Y. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06762.x · Cited by 148
Biological and Potential Therapeutic Roles of Sirtuin Deacetylases
Taylor, D. M., Maxwell, M. M., Luthi‐Carter, R., & Kazantsev, A. G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8357-y · Cited by 162
The Diversity of Histone Versus Nonhistone Sirtuin Substrates
Martínez‐Redondo, P., & Vaquero, A. (2013) · Genes & Cancer · doi:10.1177/1947601913483767 · Cited by 161
Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
He, K., & Gan, W.-J. (2023) · Cancer Management and Research · doi:10.2147/cmar.s411168 · Cited by 167
Caloric restriction and cancer: molecular mechanisms and clinical implications
Meynet, O., & Ricci, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.001 · Cited by 154
Hoffmann, E., Wald, J., Lavu, S., Roberts, J., Beaumont, C., Haddad, J., Elliott, P., Westphal, C., & Jacobson, E. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04340.x · Cited by 132
Cellular and molecular effects of sirtuins in health and disease
Horio, Y., Hayashi, T., Kuno, A., & Kunimoto, R. (2011) · Clinical Science · doi:10.1042/cs20100587 · Cited by 135
SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol
Boily, G., He, X. H., Pearce, B., Jardine, K. E., & McBurney, M. W. (2009) · Oncogene · doi:10.1038/onc.2009.147 · Cited by 148
Stimulation of Sirt1-Regulated FoxO Protein Function by the Ligand-Bound Vitamin D Receptor
An, B., Tavera-Mendoza, L. E., Dimitrov, V., Wang, X., Calderon, M. R., Wang, H., & White, J. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-10 · Cited by 148
“For example, a recent study showed that Sirt1 activity suppresses intestinal tumorigenesis in a -catenin-driven model of colon cancer in mice and that Sirt1 deacetylated -catenin and promoted its nucleocytoplasmic shuttling (19).”
BackgroundCalorie restriction and cancer prevention: a mechanistic perspective
Hursting, S. D., Dunlap, S. M., Ford, N. A., Hursting, M. J., & Lashinger, L. M. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-10 · Cited by 128
“that SIRT1 can act to suppress polyp formation in the APC intestinal tumor model [87].”
BackgroundChemically induced reprogramming to reverse cellular aging
Yang, J.-H., Petty, C. A., Dixon-McDougall, T., Lopez, M. V., Tyshkovskiy, A., Maybury-Lewis, S., Tian, X., Ibrahim, N., Chen, Z., Griffin, P. T., et al. (2023) · Aging · doi:10.18632/aging.204896 · Cited by 136
Self-citationKelly, G. S. (2010) · PubMed · Cited by 175
Dai, C. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0525 · Cited by 143
Kang, H., Jung, J.-W., Kim, M. K., & Chung, J. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006611 · Cited by 125
“, and when it is overexpressed in colonic epithelial cells, it deacetylates β-catenin and suppresses colon cancer cell growth”
BackgroundMangerich, A., & Bürkle, A. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/321653 · Cited by 122
“The DEK protein is a major nonhistone chromatin component with functions in DNA metabolism and repair on a cellular, and carcinogenesis and autoimmunity on an organismic level.”
BackgroundKavoosi, F., & Sanaei, M. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_142_19 · Cited by 130
“The role of sirtuins in carcinogenesis is still debatable, because some SIRTs have dual roles as tumor suppressors and oncoproteins.[17] Class I HDACs include HDACs 1, 2, 3, and 8 and are similar to yeast Rpd3.”
BackgroundSIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia
Sasca, D., Hähnel, P. S., Szybinski, J., Khawaja, K., Kriege, O., Pante, S. V., Bullinger, L., Strand, S., Strand, D., Theobald, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-538819 · Cited by 119
“Vice versa, conditional overexpression of Sirt1 suppressed intestinal tumor formation in Ag-presenting cell (APC) mice and reduced the frequencyof fatal tumordevelopment inp53miceong irradiation.(4,13) Contradictorily, there is rising evidence that SIRT1 can also contribute to tumorigenesis.”
BackgroundBiochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 135
“…array of age-associated disorders, including heart failure and cardiovascular disease (Hsu et al. 2008; Luo et al. 2014), different forms of cancer (Firestein et al. 2008; Lim et al. 2010; Srisuttee et al. 2012; Yuan et al. 2013), metabolic syndrome (Li 2013; Chang and Guarente 2014), and various…”
BackgroundSirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells
Buhrmann, C., Shayan, P., Popper, B., Goel, A., & Shakibaei, M. (2016) · Nutrients · doi:10.3390/nu8030145 · Cited by 124
“Indeed, it has been reported that Sirt1 blocks NF-κB signaling pathway activation, which induces inflammation and tumor invasion [42–48].”
BackgroundKim, Y. J., Hwang, S. H., Lee, S. Y., Shin, K. K., Cho, H. H., Bae, Y. C., & Jung, J. S. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0429 · Cited by 116
“Moreover, SIRT1 overexpression reduces the incidences of colon cancer in APC + / - min mice [42] and spontaneous cancers in multiple tissues of SIRT1 + / - ; p53 + / - mice [43].”
Peptide Switch Is Essential for Sirt1 Deacetylase Activity
Kang, H., Suh, J.-Y., Jung, Y.-S., Jung, J.-W., Kim, M. K., & Chung, J. H. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.038 · Cited by 111
“, 2010) and decreasing Sirt1 expression increases tumor development (Firestein et al., 2008; Wang et al., 2008).”
PCAF Acetylates β-Catenin and Improves Its Stability
Ge, X., Jin, Q., Zhang, F., Yan, T., & Zhai, Q. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0792 · Cited by 114
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012518 · Cited by 119
“For example, p38MAPK inhibitors for rheumatoid arthritis may lose efficacy because of upregulation of other proinflammatory kinase pathways (Firestein et al., 2008).”
BackgroundSong, J., Li, J., Yang, F., Ning, G., Zhen, L., Wu, L., Zheng, Y., Zhang, Q., Lin, D., Xie, C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1569-2 · Cited by 118
SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling
Holloway, K. R., Calhoun, T. N., Saxena, M., Metoyer, C. F., Kandler, E. F., Rivera, C. A., & Pruitt, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911325107 · Cited by 114
“Also, controversy has surrounded the role of SIRT1 during tumorigenesis (4, 28, 49, 50).”
BackgroundThe Biology of HDAC in Cancer: The Nuclear and Epigenetic Components
Hagelkrüys, A., Sawicka, A., Rennmayr, M., & Seiser, C. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_2 · Cited by 123
“Conversely, recent mouse studies revealed a potential role for SIRT1 as a tumor suppressor: In an APC model of colon cancer, calorie restriction-mediated SIRT1 overexpression and ectopic induction of SIRT1 reduces colon cancer cell growth by suppressing b-catenin-driven cell proliferation (Firestein et al. 2008).”
BackgroundThe role of SIRT1 in ocular aging
Mimura, T., Kaji, Y., Noma, H., Funatsu, H., & Okamoto, S. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.07.017 · Cited by 124
Colorectal cancer chemoprevention by trans-resveratrol
Juan, M. E., Alfaras, I., & Planas, J. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.010 · Cited by 123
Sirtuin 7 in cell proliferation, stress and disease: Rise of the Seventh Sirtuin!
Kiran, S., Anwar, T., Kiran, M., & Ramakrishna, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.026 · Cited by 119
A SUMOylation-Dependent Pathway Regulates SIRT1 Transcription and Lung Cancer Metastasis
Sun, L., Li, H., Chen, J., Dehennaut, V., Zhao, Y., Yang, Y., Iwasaki, Y., Kahn-Perles, B., Leprince, D., Chen, Q., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt118 · Cited by 111
“On the other hand, SIRT1 mitigates Wnt-initiated EMT by virtue of directly deacetylating β-catenin (38).”
BackgroundChen, I., Chiang, W., Huang, H.-H., Chen, P., Shen, Y., & Chiang, H. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-254 · Cited by 115
“A recent report showed that enhanced SIRT1 expression in a β-catenin-dependent mouse model of colon cancer inhibited intestinal-tumor formation, thereby indicating that the effects of SIRT1 might vary in different tumor models, and depend on the presence of appropriate downstream targets [73].”
BackgroundO-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway
Ferrer, C. M., Lu, T. Y., Bacigalupa, Z. A., Katsetos, C. D., Sinclair, D. A., & Reginato, M. J. (2016) · Oncogene · doi:10.1038/onc.2016.228 · Cited by 116
“Emerging evidence also points to SIRT1 as a critical player in tumor suppression (22) (23).”
Self-citationJang, K. Y., Noh, S. J., Lehwald, N., Tao, G., Bellovin, D. I., Park, H. S., Moon, W. S., Felsher, D. W., & Sylvester, K. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045119 · Cited by 109
“However, there are additional conflicting reports regarding the tumor suppressing capability of SIRT1 [8,20,21].”
BackgroundFancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol
Zhang, Q., Loza, L. I. M., Eaton, L., Duncan, A. W., Goldman, D. C., Anur, P., Watanabe‐Smith, K., Rathbun, R. K., Fleming, W., Bagby, G. C., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278226 · Cited by 114
Deacetylation of Nonhistone Proteins by HDACs and the Implications in Cancer
Peng, L., & Seto, E. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_3 · Cited by 113
Motilva, V., García-Mauriño, S., Talero, E., & Illanes, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00915.x · Cited by 106
“SIRT1 suppresses intestinal tumorigenesis and colon cancer growth in a b-catenin-driven mouse model of colon cancer [97].”
BackgroundInfluentialRotili, D., Tarantino, D., Nebbioso, A., Paolini, C., Huidobro, C., Lara, E., Mellini, P., Lenoci, A., Pezzi, R., Botta, G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011614 · Cited by 108
β-Catenin Regulates Hepatic Mitochondrial Function and Energy Balance in Mice
Lehwald, N., Tao, G., Jang, K. Y., Papandreou, I., Liu, B., Liu, B., Pysz, M. A., Willmann, J. K., Knoefel, W. T., Denko, N. C., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.048 · Cited by 102
Nosho, K., Shima, K., Irahara, N., Kure, S., Firestein, R., Baba, Y., Toyoda, S., Chen, L., Hazra, A., Giovannucci, E. L., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.49 · Cited by 104
Self-citationDeacetylation by SIRT1 Reprograms Inflammation and Cancer
Liu, T. F., & McCall, C. E. (2013) · Genes & Cancer · doi:10.1177/1947601913476948 · Cited by 111
Leontieva, O. V., & Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100402 · Cited by 102
“Some other genes identified in the yeast model turned out to be involved in organismal aging and age-related diseases in mammals [29-38].”
BackgroundZhou, H., Shang, L., Li, X., Zhang, X., Gao, G., Guo, C., Chen, B., Liu, Q., Gong, Y., & Shao, C. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.030 · Cited by 108
Retractedp53 as a Regulator of Lipid Metabolism in Cancer
Parrales, A., & Iwakuma, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122074 · Cited by 102
The Epigenetic Language of Circadian Clocks
Sahar, S., & Sassone‐Corsi, P. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25950-0_2 · Cited by 103
Liang, Y., Song, X., Li, Y., Sang, Y., Zhang, N., Zhang, H., Liu, Y., Duan, Y., Chen, B., Guo, R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0582-1 · Cited by 99
SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling in vivo and in vitro
Zhou, Y., Song, T., Peng, J., Zhou, Z., Wei, H., Zhou, R., Jiang, S., & Peng, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12774 · Cited by 102
“In epithelial cells, the SIRT1 deacetylation of β-catenin causes the release of β-catenin from the nucleus [35].”
BackgroundSirtuin 1 in malignant transformation: Friend or foe?
Fang, Y., & Nicholl, M. B. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.019 · Cited by 99
SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p
Sun, L., Zhi, Z., Chen, L., Zhou, Q. Y., Li, X., Gan, W.-J., Chen, S., Yang, M., Liu, Y., Shen, T., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.001 · Cited by 103
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer
Santolla, M. F., Avino, S., Pellegrino, M., De Francesco, E. M., De Marco, P., Lappano, R., Vivacqua, A., Cirillo, F., Rigiracciolo, D. C., Scarpelli, A., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.201 · Cited by 90
Frederick, D. W., Davis, J. G., Dávila, A., Agarwal, B., Michan, S., Puchowicz, M. A., Nakamaru-Ogiso, E., & Baur, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.579565 · Cited by 88
“This construct was then targeted to the Col1A1 locus as described previously (24).”
MethodXiao, Y., Yang, Y., Gan, R., Zhao, L., Li, W., Zhou, H., Wang, X., Lü, J., & Meng, Q. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098833 · Cited by 91
“SIRT1 might act as an oncogene by inhibiting tumor suppressor genes, such as p53 [36], and might act as a anti-oncogene by repressing several oncogenes or oncoproteins such as b-catenin and survivin [37,38].”
BackgroundChao, S., Chen, Y., Huang, K., Kuo, K.-L., Yang, T.-H., Huang, K., Wang, C., Tang, C., Yang, R., & Liu, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-03635-7 · Cited by 91
SIRT1: roles in aging and cancer
Kim, E.-J., & Um, S.-J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.11.751 · Cited by 88
Metabolic and Neuropsychiatric Effects of Calorie Restriction and Sirtuins
Libert, S., & Guarente, L. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183800 · Cited by 89
“For example, genetic activation of SIRT1 protects against tumors in the gut (41) and the pancreas (42), likely by suppressing β-catenin activity.”
BackgroundSelf-citationResveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Brockmueller, A., Sameri, S., Líšková, A., Zhai, K., Varghese, E., Samuel, S. M., Büsselberg, D., Kubatka, P., & Shakibaei, M. (2021) · Cancers · doi:10.3390/cancers13020188 · Cited by 91
Li, Y., Xu, S., Li, J., Zheng, L., Feng, M., Wang, X., Han, K., Pi, H., Li, M., Huang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8711 · Cited by 99
“SIRT1 may act as a tumor promoter or suppressor, depending on the tumor type, as its overexpression inhibits tumorigenesis in colon tumors and ovarian cancer [31, 32], but stimulates tumorigenesis in prostate tumors and acute myeloid leukemia [11, 33].”
BackgroundInhibition of SIRT1 deacetylase suppresses estrogen receptor signaling
Yao, Y., Li, H., Gu, Y., Davidson, N. E., & Zhou, Q. Y. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp308 · Cited by 92
“For example, studies show that SIRT1 may function as a tumor suppressor gene because SIRT1-deficient mice develop tumors in multiple tissues, whereas SIRT1 overexpression inhibits intestinal tumorigenisis in SIRT1 transgenic mice [17, 18].”
BackgroundAging and cancer cell biology, 2009
Campisi, J., & Yaswen, P. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00475.x · Cited by 85
“Moreover, it reduces the incidences of colon cancer in APC+ ⁄ min mice (Firestein et al., 2008), BRCA1-associated mammary cancer (Wang et al., 2008b), spontaneous cancers in multiple tissues of Sirt1+ ⁄ ); p53+ ⁄ ) mice (Wang et al., 2008a), and ionizing radiation-induced lymphoma in p53+ ⁄ ) mice…”
BackgroundEmerging Roles of SIRT1 in Cancer Drug Resistance
Wang, Z., & Chen, W. (2013) · Genes & Cancer · doi:10.1177/1947601912473826 · Cited by 82
Suppression of β-catenin signaling by liver X receptor ligands
Uno, S., Endo, K., Jeong, Y., Kawana, K., Miyachi, H., Hashimoto, Y., & Makishima, M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.007 · Cited by 90
SIRT1 Is Downregulated in Gastric Cancer and Leads to G1-phase Arrest via NF-κB/Cyclin D1 Signaling
Yang, Q., Wang, B., Gao, W., Huang, S., Liu, Z., Li, W., & Jia, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0214 · Cited by 91
“The expression of SIRT1 is relatively higher in hepatocellular carcinoma, breast cancer, and thyroid cancer (10, 23, 24) but lower in colon and lung cancer (15, 16, 25) compared with their corresponding normal tissues.”
BackgroundSirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 83
SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
Qiu, G., Li, X., Che, X., Wei, C., He, S., Lü, J., Jia, Z., Pang, K., & Fan, L. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.042 · Cited by 87
“SIRT1 can target proteins in the nucleus and the cytosol which are involved in regulating cancer cell proliferation, DNA damage repair, gene transcription, survival and autophagy such as histones [113], p53 [114,115], FoxO1 [116], b-catenin [117,118], Ku70 [119], NF-jB [45], survivin [120], PTEN [121], E2F1 [43], ATG5…”
BackgroundInhibition of SUV39H1 Methyltransferase Activity by DBC1
Li, Z., Chen, L., Kabra, N., Wang, C., Fang, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900956200 · Cited by 90
Vakhrusheva, O., Braeuer, D., Liu, Z., Braun, T. W., & Bober, E. (2008) · PubMed · Cited by 97
van Leeuwen, I., & Laín, S. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02005-3 · Cited by 90
“These results are in agreement with recent work using a mouse model for colon cancer (Firestein et al., 2008).”
BackgroundResultInfluentialHistone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Kim, E., Bisson, W. H., Löhr, C. V., Williams, D. E., Ho, E., Dashwood, R. H., & Rajendran, P. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150825125857 · Cited by 88
Sirtuins, Metabolism, and Cancer
Martinez-Pastor, B., & Mostoslavsky, R. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00022 · Cited by 77
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
Kim, S. Y., Dunn, I. F., Firestein, R., Gupta, P. B., Wardwell, L., Repich, K., Schinzel, A. C., Wittner, B. S., Silver, S. J., Root, D. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008979 · Cited by 91
“The other compound identified in the CMAP analysis, resveratrol, was recently shown to activate SIRT1, which promotes the deacetylation of b-catenin, ultimately leading to inhibition of transcription [27].”
BackgroundSelf-citationRepairing split ends: SIRT6, mono-ADP ribosylation and DNA repair
Van Meter, M., Mao, Z., Gorbunova, V., & Seluanov, A. (2011) · Aging · doi:10.18632/aging.100389 · Cited by 80
“Mammalian genomes encode seven Sir2 homologs (SIRT1-7); while it is unclear whether overexpression or hyperactivation of any of these sirtuins can extend lifespan, there is evidence that these genes can protect against several age-related pathologies, including neurodegeneration [9], hearing loss [10], diet induced ob…”
BackgroundNAD Biosynthesis in Humans - Enzymes, Metabolites and Therapeutic Aspects
Dölle, C., Skoge, R., VanLinden, M., & Ziegler, M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660206 · Cited by 77
Wu, M., Wei, W., Xiao, X., Guo, J., Xie, X., Li, L., Kong, Y., Lv, N., Jia, W., Zhang, Y., et al. (2012) · Medical Oncology · doi:10.1007/s12032-012-0260-6 · Cited by 83
Sergi, C. M., Shen, F., & Liu, S.-M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00093 · Cited by 81
“In other investigations, SIRT1 inhibits tumor progression, deacetylates β-catenin, drives cell proliferation, and inhibits carcinogenesis in patients harboring colon cancer (118, 119).”
BackgroundThe emerging role of lysine acetylation of non-nuclear proteins
Close, P., Creppe, C., Gillard, M., Ladang, A., Chapelle, J.-P., Nguyen, L., & Chariot, A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0252-7 · Cited by 88
“As a result, induction of SIRT1 in a b-catenin-driven mouse model of colon cancer reduces tumour formation [98].”
BackgroundPreclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells
Chauhan, D., Bandi, M. L., Singh, A., Ray, A., Raje, N. S., Richardson, P. G. G., & Anderson, K. C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08888.x · Cited by 89
Trending topics of SIRT1 in tumorigenicity
Garcia-Peterson, L. M., & Li, X. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129952 · Cited by 78
Adlakha, Y. K., & Saini, N. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.46 · Cited by 78
“On the contrary, Firestein et al.46 showed that induction of SIRT1 suppresses intestinal tumorigenesis and colon cancer growth.”
BackgroundImpact of curcumin on sirtuins: A review
Zendedel, E., Butler, A. E., Atkin, S. L., & Sahebkar, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27371 · Cited by 80
“According to the recent studies, SIRT1 targets β‐catenin, promoting the shuttling of the oncogenic form of β‐catenin from the nucleus to the cytoplasm.(64) Other reports suggest that SIRT1 might serve as a tumor promoter in some types of cancers.”
BackgroundHu, A., Huang, J., Li, R., Lu, Z., Duan, J., Xu, W., Chen, X., & Fan, J. (2015) · Scientific Reports · doi:10.1038/srep13429 · Cited by 83
Are sirtuins markers of ovarian aging?
Zhang, J., Li, F., Lu, Z., Xiong, J., Wu, M., Shi, L., Luo, A., & Wang, S. (2015) · Gene · doi:10.1016/j.gene.2015.09.043 · Cited by 79
Balance between SIRT1 and DBC1 expression is lost in breast cancer
Sung, J., Kim, R., Kim, J., & Lee, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01573.x · Cited by 83
SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer
Rifai, K. T., Judes, G., Idrissou, M., Daures, M., Bignon, Y., Penault-Llorca, F. M., & Bernard-Gallon, D. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25771 · Cited by 83
“For example, SIRT1 can deacetylate and downregulate the activity of tumor suppressor enzymes such as p53 [23], p73 [24], E2F1 [25], and Forkhead box proteins FOXO transcription factors [26], but also oncogenes such as NFkappaB [27], STAT3 [28], Survivin [29] and β-Catenin [30].”
BackgroundMu, N., Lei, Y., Wang, Y., Wang, Y., Duan, Q., Ma, G., Liu, X., & Su, L. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01559-3 · Cited by 76
Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes
Motonishi, S., Nangaku, M., Wada, T., Ishimoto, Y., Ohse, T., Matsusaka, T., Kubota, N., Shimizu, A., Kadowaki, T., Tobe, K., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030289 · Cited by 76
SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging
Blum, C. A., Ellis, J. L., Loh, C., Ng, P. Y., Perni, R. B., & Stein, R. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100861p · Cited by 73
Bases biomoleculares do fotoenvelhecimento
Montagner, S., & Costa, A. (2009) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962009000300008 · Cited by 72
Anthocyanins/anthocyanidins and colorectal cancer: What is behind the scenes?
Moraes, L. F. D. S., Sun, X., Pelúzio, M. D. C. G., & Zhu, M. J. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357533 · Cited by 79
“Interestingly, the expression of sirtuin 1 (SIRT1), which has been demonstrated to trigger autophagy (Lee et al., 2008) and inhibit b-catenin pathway (Firestein et al., 2008), was also increased with illawarra plum extract treatment (Symonds, Konczak, and Fenech, 2013).”
BackgroundSIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines
Qu, Y., Zhang, J., Wu, S., Li, B., Liu, S., & Cheng, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.025 · Cited by 78
Metadata
- Authors
- Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., Hahn, W. C., Guarente, L. P., & Sinclair, D. A.
- Affiliations
- Broad Institute (US)
- Massachusetts Institute of Technology (US)
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e2020
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2289879
- OpenAlex
- W2158153532
- Cited by
- 588
- References
- 34
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 12 · 2023: 29 · 2022: 11 · 2021: 25 · 2020: 15 · 2019: 31 · 2018: 37 · 2017: 25 · 2016: 38 · 2015: 31 · 2014: 40 · 2013: 60 · 2012: 46
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-06)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Glenn Foundation for Medical Research
- National Space Biomedical Research Institute
- National Institutes of Health (NIH T32)
- National Institute on Aging (R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- SIRT1, NAD+-dependent deacetylase, caloric restriction, intestinal tumorigenesis, colon cancer, β-catenin, protein deacetylation, cytoplasmic localization, cell proliferation, longevity genes
- MeSH terms
- Animals, Cell Nucleus, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Models, Biological, Rats, Inbred F344, Gene Expression Regulation, Neoplastic, Sirtuins, Cell Proliferation, beta Catenin, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.